Exagen Inc. achieves its 1,000,000th AVISE CTD test, enhancing autoimmune disease diagnosis and patient care.

Test you again if previous autoimmune disease tests were inconclusive (not helpful or insightful in making a diagnosis) If you’re interested in having the AVISE® CTD test performed by your doctor, the ...

Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTD Dec. 12, 2024 9:00 AM ET Exagen Inc. (XGN) GlobeNewswire ...

The AVISE CTD test that rheumatologists have come to know and trust is composed of multiple biomarker assays that assist in the clinical diagnosis of the most common CTDs, which included: SLE RA ...

Exagen (XGN) announced the completion of its 1,000,000th AVISE CTD test, marking a significant milestone that underscores the company’s dedication to supporting patients and clinicians managing ...

ALBUQUERQUE, NM and SAN DIEGO, CA, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Exagen Diagnostics will feature 5 presentations highlighting the usefulness of AVISE ® testing at the American College of ...

Key Points - Revenue (GAAP) rose to $17.2 million, surpassing analyst expectations by 5.5% and grew 14.2% year over year. AVISE CTD test volume increased 14% sequentially, and the trailing-twelve ...